
Tuesday, May 20, 2025 2:00:59 PM
kim announced the building of those facilities in pr's...he announced when they began production...im not sure how anyone invested does not know this...you wont learn anything positive from webslinger...but if you post something negative he will feed your negativity with bullshit he knows isnt true...
i didnt read the 10q because i knew there was nothing in there to bother with....if i have a need to look for something, i will go through it...so i will take your word for it that there is no mention of facilities in Lam Dong...so if its not in there, then i guess its not in there...
but heres another for you from March:
"Kraig Biocraft Laboratories Confirms Operations in Vietnam’s Silk Production Hub, Lam Dong Province
ANN ARBOR, Mich., March 17, 2025 — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs“), a world leader in spider silk manufacturing, is pleased to confirm it has established production operations in Lam Dong Province, Vietnam.'
something tells me they are not doing it from an "office space" as some nitwits would have you believe...
Recent KBLB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2025 09:10:15 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2025 08:30:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2025 08:30:48 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/30/2025 04:15:09 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/29/2025 11:37:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/17/2025 09:00:55 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/17/2025 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2025 08:44:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2025 09:09:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/28/2025 08:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2025 08:30:35 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/14/2025 05:11:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/13/2025 10:21:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2025 10:14:03 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 12/19/2024 09:30:04 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/19/2024 09:05:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 09:30:40 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM